X-raying The First Biosimilar to Tysabri for Multiple Sclerosis and Crohn’s Disease Approved By The FDA

X-raying The First Biosimilar to Tysabri for Multiple Sclerosis and Crohn’s Disease Approved By The FDA

In a significant stride for medical advancements, the U.S. Food and Drug Administration (FDA) has granted approval to Tyruko (natalizumab-sztn),…

Read More »